ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, cilt.18, sa.14, ss.2032-2041, 2018 (SCI-Expanded)
Objective: Breast cancer is one of the most common diseases among women worldwide and it is characterized by a high ratio of malignancy and metastasis and low rate of survival of patients. Due to limited treatment options, the discovery of alternative therapeutic agents and clarifying the molecular mechanism of breast cancer development may offer new hope for its treatment. Lichen secondary metabolites may be one of these therapeutic agents.